The global demand for Slide Stainer Market is presumed to reach the market size of nearly USD 8.32 MN by 2028 from USD 4.92 MN in 2021 with a CAGR of 7.8% under the study period 2022 - 2028.
Slide stainer is a chemical substance used for imparting stain to tissues and cells, which further assists in microscopic identification and makes cellular research easy. The slide stainer machine automates the staining of prepared cytology and histology tissue specimens by spreading dyes into the specimen by surface adsorption, direct staining, mordant staining, or indirect staining. The procedures employed in the automated slide stainer are linear transport and rotating transport.
Slide stainer products are in huge demand due to the increasing cases of cancer, chronic illnesses, and infectious diseases. The rising geriatric population, usage of AI in histopathology, surge in cancer screening, and increasing cancer drug trials. The rapid, efficient, and high throughput features of the semi-automated and automated slide staining systems are leading to the market expansion of slide stainers. In addition, the growth in this market will be driven by the increasing number of diagnostic centers, a growing patient base, and improved healthcare infrastructure. Furthermore, technological advancements in the healthcare industry, increasing adoption of automated slide stainers, rising demand for slide stains in diagnostic facilities and clinical research, and a surge in laboratory automation procedures are factors propelling the market growth for slide stainers.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of slide stainer. The growth and trends of slide stainer industry provide a holistic approach to this study.
This section of the slide stainer market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
- Reagents (Stains Diluents & Buffers, Blocking Sera & Reagents, Mounting Media Fixative Reagents And Embedding Media, Probes, Antibodies)
- Equipment (Automated & Semi-Automated Slide Stainer, Manual Staining Set)
- Consumables & Accessories
- Hematoxylin And Eosin
- Special Stains
- In-Situ Hybridization
By End User
- Disease Diagnosis (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Lung Cancer, Other Diseases)
- Medical Research
- Hospitals & Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Other End Users
This section covers the regional outlook, which accentuates current and future demand for the Slide Stainer market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Slide Stainer Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the slide stainer market include F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Thermo Fisher Scientific, Inc. (US), Merck KGAA (Germany), Agilent Technologies, Inc. (US), Abcam Plc. (UK), Becton, Dickinson and Company (US), Siemens Healthineers AG (Germany), Biocare Medical, LLC (US), Hardy Diagnostics (US), General Data Company (US), ELITechGroup (France), Biogenex (US), Histo-Line Laboratories (Italy), SLEE medical GmbH (Germany), Amos scientific Pty Ltd. (Australia), MEDITE Medical GMBH (Germany), Cellpath Ltd (UK), Diapath S.P.A. (Italy), Bio SB, Inc. (US), Rockland Immunochemicals, Inc. (US), Cell Signaling Technology, Inc. (US), Diagnostic BioSystems, Inc. (US), and Dakewe Biotech Co., Ltd. (China). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.